BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 28235567)

  • 1. CRIF1 enhances p53 activity via the chromatin remodeler SNF5 in the HCT116 colon cancer cell lines.
    Yan HX; Zhang YJ; Zhang Y; Ren X; Shen YF; Cheng MB; Zhang Y
    Biochim Biophys Acta Gene Regul Mech; 2017 Apr; 1860(4):516-522. PubMed ID: 28235567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CR6-interacting factor 1 represses the transactivation of androgen receptor by direct interaction.
    Suh JH; Shong M; Choi HS; Lee K
    Mol Endocrinol; 2008 Jan; 22(1):33-46. PubMed ID: 17885209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CR6-interacting factor 1 interacts with Gadd45 family proteins and modulates the cell cycle.
    Chung HK; Yi YW; Jung NC; Kim D; Suh JM; Kim H; Park KC; Song JH; Kim DW; Hwang ES; Yoon SH; Bae YS; Kim JM; Bae I; Shong M
    J Biol Chem; 2003 Jul; 278(30):28079-88. PubMed ID: 12716909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CR6-interacting factor 1 interacts with orphan nuclear receptor Nur77 and inhibits its transactivation.
    Park KC; Song KH; Chung HK; Kim H; Kim DW; Song JH; Hwang ES; Jung HS; Park SH; Bae I; Lee IK; Choi HS; Shong M
    Mol Endocrinol; 2005 Jan; 19(1):12-24. PubMed ID: 15459248
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of MYC by the SMARCB1 tumor suppressor.
    Weissmiller AM; Wang J; Lorey SL; Howard GC; Martinez E; Liu Q; Tansey WP
    Nat Commun; 2019 May; 10(1):2014. PubMed ID: 31043611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CRIF1 interacting with CDK2 regulates bone marrow microenvironment-induced G0/G1 arrest of leukemia cells.
    Ran Q; Hao P; Xiao Y; Xiang L; Ye X; Deng X; Zhao J; Li Z
    PLoS One; 2014; 9(2):e85328. PubMed ID: 24520316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CRIF1 siRNA-Encapsulated PLGA Nanoparticles Suppress Tumor Growth in MCF-7 Human Breast Cancer Cells.
    Piao S; Lee I; Kim S; Park H; Nagar H; Choi SJ; Vu GH; Kim M; Lee EO; Jeon BH; Kim DW; Seo Y; Kim CS
    Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inactivation of the Snf5 tumor suppressor stimulates cell cycle progression and cooperates with p53 loss in oncogenic transformation.
    Isakoff MS; Sansam CG; Tamayo P; Subramanian A; Evans JA; Fillmore CM; Wang X; Biegel JA; Pomeroy SL; Mesirov JP; Roberts CW
    Proc Natl Acad Sci U S A; 2005 Dec; 102(49):17745-50. PubMed ID: 16301525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymphocyte-specific protein tyrosine kinase (Lck) interacts with CR6-interacting factor 1 (CRIF1) in mitochondria to repress oxidative phosphorylation.
    Vahedi S; Chueh FY; Chandran B; Yu CL
    BMC Cancer; 2015 Jul; 15():551. PubMed ID: 26210498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EVI1 targets ΔNp63 and upregulates the cyclin dependent kinase inhibitor p21 independent of p53 to delay cell cycle progression and cell proliferation in colon cancer cells.
    Nayak KB; Kuila N; Das Mohapatra A; Panda AK; Chakraborty S
    Int J Biochem Cell Biol; 2013 Aug; 45(8):1568-76. PubMed ID: 23665236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased DNA damage sensitivity and apoptosis in cells lacking the Snf5/Ini1 subunit of the SWI/SNF chromatin remodeling complex.
    Klochendler-Yeivin A; Picarsky E; Yaniv M
    Mol Cell Biol; 2006 Apr; 26(7):2661-74. PubMed ID: 16537910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Essential role of CR6-interacting factor 1 (Crif1) in E74-like factor 3 (ELF3)-mediated intestinal development.
    Kwon MC; Koo BK; Kim YY; Lee SH; Kim NS; Kim JH; Kong YY
    J Biol Chem; 2009 Nov; 284(48):33634-41. PubMed ID: 19801644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p53-Dependent transcriptional repression of c-myc is required for G1 cell cycle arrest.
    Ho JS; Ma W; Mao DY; Benchimol S
    Mol Cell Biol; 2005 Sep; 25(17):7423-31. PubMed ID: 16107691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N-methylpurine DNA glycosylase inhibits p53-mediated cell cycle arrest and coordinates with p53 to determine sensitivity to alkylating agents.
    Song S; Xing G; Yuan L; Wang J; Wang S; Yin Y; Tian C; He F; Zhang L
    Cell Res; 2012 Aug; 22(8):1285-303. PubMed ID: 22801474
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ING1 represses transcription by direct DNA binding and through effects on p53.
    Kataoka H; Bonnefin P; Vieyra D; Feng X; Hara Y; Miura Y; Joh T; Nakabayashi H; Vaziri H; Harris CC; Riabowol K
    Cancer Res; 2003 Sep; 63(18):5785-92. PubMed ID: 14522900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. COMMD9 promotes TFDP1/E2F1 transcriptional activity via interaction with TFDP1 in non-small cell lung cancer.
    Zhan W; Wang W; Han T; Xie C; Zhang T; Gan M; Wang JB
    Cell Signal; 2017 Jan; 30():59-66. PubMed ID: 27871936
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CR6-interacting factor 1 is a key regulator in Aβ-induced mitochondrial disruption and pathogenesis of Alzheimer's disease.
    Byun J; Son SM; Cha MY; Shong M; Hwang YJ; Kim Y; Ryu H; Moon M; Kim KS; Mook-Jung I
    Cell Death Differ; 2015 Jun; 22(6):959-73. PubMed ID: 25361083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Che-1 modulates the decision between cell cycle arrest and apoptosis by its binding to p53.
    Desantis A; Bruno T; Catena V; De Nicola F; Goeman F; Iezzi S; Sorino C; Gentileschi MP; Germoni S; Monteleone V; Pellegrino M; Kann M; De Meo PD; Pallocca M; Höpker K; Moretti F; Mattei E; Reinhardt HC; Floridi A; Passananti C; Benzing T; Blandino G; Fanciulli M
    Cell Death Dis; 2015 May; 6(5):e1764. PubMed ID: 25996291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LKB1 is recruited to the p21/WAF1 promoter by p53 to mediate transcriptional activation.
    Zeng PY; Berger SL
    Cancer Res; 2006 Nov; 66(22):10701-8. PubMed ID: 17108107
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-Resolution 4C Reveals Rapid p53-Dependent Chromatin Reorganization of the CDKN1A Locus in Response to Stress.
    Millau JF; Wijchers P; Gaudreau L
    PLoS One; 2016; 11(10):e0163885. PubMed ID: 27741251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.